Surgery Websites
Department of Surgery »  Faculty »  General Surgery »  Kenzo Hirose, M.D.
Kenzo Hirose, M.D.

Kenzo Hirose, M.D.

Associate Professor of Surgery
Division of General Surgery
Associate Director,  General Surgery Residency Program

Contact Information

Phone: (415) 502-5577
Fax: (415) 502-2236
Kenzo.Hirose@ucsf.edu

 
Open Popup

1995, AB, Harvard University, Biochemical Sciences
1999, MD, Harvard Medical School

  • 2000, Internship, University of California, San Francisco, General Surgery
  • 2006, Residency, University of California, San Francisco, General Surgery
  • 2007, Fellowship, Cleveland Clinic Foundation, Liver Transplantation
  • 2008, Fellowship, Cleveland Clinic Foundation, Hepatobiliary Surgery
  • American Board of Surgery
  • Hepatobiliary and Pancreas Surgery Program

Dr. Kenzo Hirose is a general surgeon specializing in benign and malignant conditions of the liver, pancreas and bile duct. He has a special interest in minimally invasive surgical techniques and conducts research in patient outcomes after surgery.   

Dr. Kenzo Hirose received his medical degree from Harvard Medical school. He did his residency in general surgery at the University of California, San Francisco and his Hepatopancreatobiliary Fellowship at the Cleveland Clinic. 

MOST RECENT PUBLICATIONS FROM A TOTAL OF 44
Data provided by UCSF Profiles, powered by CTSI
  1. Wisneski AD, Jin C, Huang CY, Warren R, Hirose K, Nakakura EK, Corvera CU. Synchronous Versus Metachronous Colorectal Liver Metastasis Yields Similar Survival in Modern Era. J Surg Res. 2020 Aug 13; 256:476-485. View in PubMed
  2. Wisneski AD, Carter J, Nakakura EK, Posselt A, Rogers SJ, Cello JP, Arain M, Kirkwood KS, Hirose K, Stewart L, Corvera CU. Ampullary stenosis and choledocholithiasis post Roux-En-Y gastric bypass: challenges of biliary access and intervention. HPB (Oxford). 2020 Apr 24. View in PubMed
  3. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. A novel stratification of mesenteric mass involvement as a predictor of challenging mesenteric lymph node dissection by minimally invasive approach for ileal neuroendocrine tumors. J Surg Oncol. 2020 Aug; 122(2):204-211. View in PubMed
  4. Bongiovanni T, Hansen K, Lancaster E, O'Sullivan P, Hirose K, Wick E. Adopting best practices in post-operative analgesia prescribing in a safety-net hospital: Residents as a conduit to change. Am J Surg. 2020 02; 219(2):299-303. View in PubMed
  5. Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2019 Dec 11. View in PubMed
  6. View All Publications

 

Site Directory
    X